AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2017
Oct 16, 2017
3138_iss_2017-10-16_c2caccf0-0a13-48a3-8b9f-ba1a43c827a3.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Alligator Bioscience AB
Holder
Investor AB
Instrument
| Instrument | Shares SE0000767188 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 13/10/2017 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 3,051,600 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 3,051,600 | |
| Percentage | ||
| Directly held shares | 4.27 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 4.27 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.27 % | 3,051,600 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
||
| first paragraph, line 3 | ||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.27 % | 3,051,600 |
| Chain of controlling companies Voting rights % Voting rights Company |
||
| 3,051,600 4.27 Duba AB Group total holdings |
||
| Voting rights 3,051,600 |
||
| Percentage of voting rights 4.27 | ||
| Published 16/10/2017 15:15 |
||
| Contact | ||
| Name Petra Hedengran |
||
| Phone +4686142000 |
Email [email protected] | |
| *Source of information has chosen not to submit the data | ||
| CLOSE |
||
| [email protected] Tfn 08-408 980 37 Fax 08-24 39 25 |
More from Alligator Bioscience
AGM Information
2026
May 6
AGM Information
2026
May 6
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27